Influence of biospecimen variables on proteomic biomarkers in breast cancer
about
The PI3K/Akt Pathway in Tumors of Endocrine TissuesActive monitoring of formaldehyde diffusion into histological tissues with digital acoustic interferometry.Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis.Immunohistochemistry of colorectal cancer biomarker phosphorylation requires controlled tissue fixation.Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.Proteomics in cancer biomarkers discovery: challenges and applications.Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors.A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.Using tissue samples for proteomic studies-critical considerations.Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial.Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.Molecular determinants of post-mastectomy breast cancer recurrence
P2860
Q26770404-4D217E8E-5C32-4E24-9601-FA0C1B703709Q30363844-A5451220-664E-4DAA-88E6-2421D9CBDD4EQ33602963-0807BD88-21ED-4DB4-8CEA-9E8257A0032AQ35436560-C3EFB7A3-CB97-4225-93BD-02A21D0B5F8AQ35574950-74EBDBF6-7F0B-44C8-BE45-B4A3DF201E56Q35592114-0D9DEE47-5C5B-46A6-AEEA-547AE79F00C1Q35714211-50E140C5-090B-42B1-B57E-AB4DFC414027Q35760892-B56F1987-021E-4CF7-BE03-1810A2C3C263Q36051560-657767EC-CF43-4675-8278-23DC02D50AF8Q36141688-8579E3B5-A8A8-4A81-9EA6-94ED5CFA1A5AQ36270508-979B1033-5F34-43D2-81CD-146887908A3AQ36822535-6417B191-8A2E-429A-8DB7-CB0ED1D4A86EQ38315127-ED05F7D0-9BA1-47EF-A58D-CE392BB6DCCEQ38391252-4CCE73B1-6E59-40CC-95F9-D869B3E62583Q38824059-D9A9D998-12C7-40DC-92E6-7FFFD7E08A71Q38963132-BD60F57F-EA66-4955-BFE5-D218317060DAQ42362672-BADE92D0-9F19-47BD-A696-49B6182412E0Q47577143-28447528-5F0D-4DE6-B80E-B18CA9F380C9Q57815585-9A8D13F2-E52D-462F-80DF-407F9563513F
P2860
Influence of biospecimen variables on proteomic biomarkers in breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@ast
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@en
type
label
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@ast
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@en
prefLabel
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@ast
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@en
P2093
P2860
P1476
Influence of biospecimen variables on proteomic biomarkers in breast cancer
@en
P2093
Ana Maria Gonzalez-Angulo
Argun Akcakanat
Aysegul Sahin
Beatriz E Adrada
Elizabeth Mittendorf
Emily Tarco
Gildy Babiera
Gopal Singh
Gordon B Mills
Huiqin Chen
P2860
P304
P356
10.1158/1078-0432.CCR-13-1507
P407
P577
2014-06-03T00:00:00Z